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Abstract: Males of Poecilia reticulata showed extreme diversity in color, particularly of their fins, while the females 
lack the bright colors and are largely whitish. Such extreme variability of color and finnage lead to demand of males 
in the markets. The aim of present work was to develop a new Letrozole (LTZ)-loaded PLGA nanoparticles for  
effective delivery of the masculinization drug, letrozole, as an alternative to commercially available masculinization 
agents. The LTZ-loaded PLGA NPs were prepared by solvent displacement technique. The particle size of  
LTZ-loaded PLGA NPs was analyzed using LICOMP particle size analyzer and was found to be in the range of 72 
nm to 520 nm with average size of 221.5±63.3 nm. Zeta potential was estimated to be about 21.35 mV with loading 
efficiency of 43.63±4.63 %. In the present study, a series of experiments were carried out to induce masculinization 
using LTZ-loaded PLGA nanoparticles during the sex differentiation period. Guppy (P. reticulate) fry were treated 
with LTZ-loaded PLGA nanoparticles at dosages 5, 25, 50 and 100 ppm/kg diet for 10, 15 and 30 days. The gonopodium 
index and GSI showed increasing order in male and female respectively with dose of LTZ-loaded nanoparticles. The  
results indicated an increase in the proportion of males with dosage and duration of treatment. This has been done 
for the first time using nanotechnology efficiently which has shown an  increase in the male population of Poecilia 
reticulata with lesser dose of nano-encapsulated  Letrozole (LTZ)-loaded PLGA nanoparticles drug as compared 
with naked control Letrozole (LTZ) drug delivery. 
Keywords:, Letrozole, Masculinization Nanoparticle PLGA, Poecilia reticulata 
INTRODUCTION 
Among aquarium fishes, guppy (Poecilia reticulata) is 
probably the most popular next to goldfish. It was 
originally called “the millions fish” because of its 
widespread distribution from the Caribbean islands of 
St. Lucia, Barbados and Trinidad to northern part of 
South America.  Another name used is rainbow fish, 
because the male is colorful in patches of red, orange, 
yellow, green, and violet, with a few black spots. 
Males are extremely variable in color, while the  
females lack the bright colors and are largely whitish. 
Such extreme variability of color and finnage enthused 
aquarists to develop many beautiful strains as seen 
today (Hallgren et al., 2006). 
The process of aromatization and activation of aromatase 
enzyme complex that leads to yield of estrone and  
estradiol from androgen precursors and also inhibition 
mechanism of aromatase enzyme complex is described 
by Pasmanik and Callard (1988) and Brodie (1991).   
There are two types of aromatase inhibitors viz, natural 
and synthetic.  Androstenedione and testosterone are 
natural inhibitors, whereas Fadrozole, Letrozole,  
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Anastrozole and Aminoglutethimide are the synthetic  
inhibitors. Natural aromatase inhibitors act by  
hydroxylation which gives rise to an unbreakable  
covalent bond thus permanently blocking off aromatase 
enzyme complex, while synthetic inhibitors reversibly 
bind to the enzymes active site. Letrozole, as described 
is a synthetic drug and has affinity for the group of 
aromatase enzyme. This makes letrozole a selective 
and potent inhibitor (Brodie, 1991). 
Although in fish, as in other animals, sex is genetically 
determined; in many cases it has been possible to  
manipulate the sex through hormone administration. If 
the fry are fed a diet containing sex steroids before 
natural sex differentiation takes place, they will develop 
as males or as females, depending on the hormone used. 
The application of androgen or estrogen to the developing 
embryo or juvenile fish overrides the endogenous sex 
determining mechanism and directs it in a male or  
female direction or induces sterility by completely 
inhibiting gonadal development. However, use of such 
hormones is always associated with certain controversies 
such as induction of sterility and residual effects on the 
organism (Hallgren et al., 2006). To avoid such  
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controversies, it is always desirable to use these hormonal 
preparations in minimum dose. But to get the desired 
effect of these drugs, it is necessary either to increase 
the dose of the drug or develop a method of delivery 
which will give desired effect at minimum dose of it. 
Nanotechnology based delivery system can be used to 
get the result using minimum dose of the drug. 
Nanoparticles (NPs) are believed to be the best drug 
delivery system, have substantial potential for drug 
targeting and exhibit several advantages over  
conventional delivery systems (Hughes, 2005). Since 
the application of nanoparticle is always associated 
with the concern of its ill effect, biodegradable polymeric 
nanoparticles have recently been the choice of the  
researchers. These polymers have already been used as 
carriers for anticancer agents (Brigger et al., 2002; 
Vauthier et al., 2003). With this background, the  
present research work was designed to develop 
nanoparticles of PLGA loaded with Letrozole feed for 
producing all male population of P. reticulate. 
The aim of present work was to develop a new  
Letrozole (LTZ)-loaded PLGA nanoparticles for effective 
delivery of the masculinization drug, letrozole (non-steroid) 
as an alternative to commercially available masculinization 
agents, which are steroids.  
MATERIALS AND METHODS 
Chemicals used: Poly(D,L-lactide-co– glycolide) lactide: 
glycolide (50:50), mol wt 30,000-60,000, Fadrozole  
hydrochloride (4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5
-yl)-benzonitrile) ≥98% (HPLC) and Poloxamer 188 
(Kolliphor® P 188 , Poly(ethylene glycol)-block- poly
(propylene glycol)-block-poly(ethylene glycol) were purchased 
from Sigma Chemical Co. (USA). All other chemicals and 
solvents were of analytical grade and purchased from Merck 
India. Letrozole (Sigma Chemical Co. (USA), molecular 
formula (C17H11N5) and chemical name 4,4′-(1H-1,2,4 
-Triazol-1-ylmethylene) bisbenzonitrile was procured from 
local dealer.  
Preparation of LTZ-loaded PLGA NPs: The PLGA 
nanoparticles and the nanoparticles loaded with Letrozole 
were prepared by solvent displacement technique 
(Mondal et al., 2008) with some alteration. To prevent 
aggregation, the internal phase, acetone from the  
nano-dispersion was evaporated with slow stirring at 
room temperature instead of quick rotative evaporation 
under partial vacuum. 
Characterization of nanoparticles: LICOMP particle 
size analyze was used for measurement of size and 
zeta potential of the nanoparticles developed. The  
surface morphology (roundnesss, smoothness and  
formation of aggregates) was studied by Atomic force  
microscopy and Scanning electron microscope.  
Loading efficiency of drug: The loading efficiency of 
LTZ was calculated by Spectrophotometry (Libra S32 
PC) at 213 nm against standard LTZ sample and 
PLGA nanoparticle. 
Preparation of diet: The diet used in present study 
was commercially available and hatchling (fry) feed 
(first bite) was procured  from Hikari, Japan. About 
100g of feed was weighed and used for incorporation 
of PLGA conjugated Letrozole. 
Incorporation of LTZ-loaded PLGA NPs into fish 
feed: PLGA NPs conjugated LTZ were incorporated into 
the feed as follows: The appropriate amount of LTZ 
-loaded PLGA NPs i.e. 5, 25, 50, 100 mg (weighed  
accurately using an electrical balance) was dissolved in 
50ml of 95% acetone. The required quantity of powdered 
feed was taken in an enamel tray and the LTZ-loaded 
PLGA NPs dissolved in acetone were sprayed uniformly 
using a chromatogram column sprayer. 
Preparation of negative control: The negative control 
diet was prepared in the same manner using only the  
solvent (acetone). 
Preparation of positive control: The positive control 
diet was prepared in the same manner using only 
100mg pure Letrozole in the solvent (acetone). 
Incorporation of PLGA NPs into fish feed: PLGA 
nanoparticles incorporation into the diet was accomplished 
as follows: The appropriate amount of PLGA nanoparticles 
that is 20 mg (weighed accurately using an electrical 
balance) was dissolved in 50ml of 95% acetone. The 
required quantity of powdered feed was taken in an 
enamel tray and the PLGA nanoparticles dissolved  
acetone was sprayed uniformly using a chromatogram 
column sprayer. 
Development of brood-stock: The brooders were 
reared in cemented tank (6×4×3ft) until they are  
matured. The gravid female and male swordtail 
(identified based on their external characteristics) were 
released in aquaria (2×1×1ft) in the ratio of 2:1 (F: M). 
The fish were fed twice daily on artificial diet as well 
as mosquito larvae, tubifex, bloodworm, earth worm 
and zooplankton at libido. 
Seed production of guppy: The female and male 
brooders were placed in a breeding trap to provide 
easy passage for the newly released young one. In 
about two weeks of their holdings, the parturition took 
place. The resultant fry (released in batches) were used 
for experimentation. The aquaria were aerated using an 
air blower. 
LTZ-loaded PLGA NPs administration to fry:  
Trial 1: This trial was conducted for 10 days. The  
two-day-old fry (intial weight 6.13mg) were divided 
into 7 groups of 35 each and designated as T1, T2, T3, 
T4, T5, T6 and T7 for negative control, positive control, 
PLGA nanoparticle (20 ppm) and 5, 25, 50 and 
100ppm of LTZ-loaded PLGA NPs respectively. 
Fishes were fed daily (100% body weight) for the first 
ten days. 
Trial 2: This trial was conducted for 15 days. The  
one-day-old fry (initial weight 3.98mg) were divided 
into 7 groups of 30 each and designated as T1, T2, T3, 
T4, T5, T6 and T7 for negative control, positive control, 
PLGA nanoparticle (20 ppm) and 5, 25, 50 and 
100ppm of LTZ-loaded PLGA NPs respectively. They 
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were fed daily @ 100% body weight for the first ten 
day and 75% for the next 5 days (11th and 15th day). 
Trial 3: This trial was conducted for 30 days. The two
-day-old fry (initial weight 4.0mg) were divided into 7 
groups of 45 each and designated as T1, T2, T3, T4, T5, 
T6 and T7 for negative control, positive control 
(100ppm pure letrozole without nanoparticles), PLGA 
nanoparticle (20 ppm) and 5, 25, 50 and 100ppm of 
LTZ-loaded PLGA NPs respectively. They were  
provided feed daily @ 100% body weight for the first 
ten days, 75% for the next 15 days and 50% for the last 5 
days. 
Evaluation of all treatments: On termination of the 
experiments, all the surviving fish were harvested, 
counted and measured for weight and length and sexed 
by macroscopic inspection. The phenotypic sex of the 
treated and control fish was determined with the help 
of secondary sexual characters, such as the shape of 
the belly, presence of gonopodium, size of  
gonopodium, and modification of anal fin. 
Gonopodial and gonosomatic index study: The stan-
dard length and the length of the gonopodium were 
measured for each fish. The gonopodial index (GPI) 
was calculated in terms of the gonopodial length as a 
percentage of the total body length. Then the whole 
body weight and the testes wet weight were measured 
for each fish.  
The gonosomatic index (GSI) was calculated in terms 
of the gonadal weight as a percentage of the whole 
body weight.  
The gonosomatic index (G.S.I.) for treated and control 
guppy was determined using the formula: 
 
 Statistical analysis: Data on percentage of male  
produced in each treatment was analyzed using one 
way ANOVA   to test the significant difference of 
mean values and standard error using SPSS 18  
software. 
RESULTS 
Physiochemical characterization of PLGA and LTZ
-loaded PLGA NPs: The particle size of the PLGA 
nanoparticles was found to be in the range of 18±63.8 
nm to 568±63.8 nm with an average size of 132.8±64.8 
nm and the PLGA-loaded letrozole nanoparticles (LTZ
-PLGA NPs) were found to be in the range of 78±38.5 
nm to 487±73.8 nm with an average size of 216.7±73.5 
nm (Table 1). 
Loading efficiency of LTZ with PLGA nanoparticles: 
The loading efficiency of LTZ calculated by  
Spectrophotometry (Libra S32 PC) measurement at 
wavelength (200 nm) against standard LTZ sample and 
PLGA nanoparticle was 48.57±6.84 %. 
Male and female percentage and survival rate: The 
male percentage was 89.63±0.93for T7 at 10 days, 
92.64±1.63% for T7 at 15 days and 100 % for both T6 
(50ppm) and T7 (100 ppm) at 30 days, lowest male 
percentage was found at T4 treatment of all groups. It 
was reported that the male percentage of treatment T2 
(naked letrozole at 50 ppm) and treatment T4  
(LTZ- PLGA NPs at 5 ppm) were 83.69±0.94% and 
82.63±1.74% respectively for 30 days treatment. These 
finding shows that LTZ in nano forms can reduce 
about 90% of prescribed dose of letrozole for  
masculinization of ornamental fishes.  
It was observed that the percentage of male production 
in treatment T4 during 10 and 30 days’ time interval 
was increased from 56.63±0.84 to 82.63±1.74%. It is 
‘therefore’ administrated  LTZ- PLGA NPs at low 
dose ( 5ppm per kg) for prolong period, presented  
significant sex reversal and also helped  to reduce cost 
of drug and its adverse impact on experimental fishes. 
The sex ratio was significantly (P<0.001) altered in the 
LTZ-PLGA NPs treated groups in  compare to control 
groups in all treatments with respect to trials and doses 
except T3 which has  PLGA nanoparticle without  
letrozole (drug) and check the impact of nanoparticle 
on experimental fishes (Table 2). 
Gonopodial index (GPI): There was a significant  
difference in the GPI between the control group and 
treated groups except PLGA nanoparticles fed groups. It 
was reported that gonopodium development was  
stimulated significantly (P<0.001) in all the LTZ –loaded 
PLGA NPs treated groups in compare to  control and T3 
as indicated by higher gonopodial index values. GPI was 
significantly increased from T4 to T7 (Table 3). 
Gonadosomatic index (GSI): It was observed that,  
increase in the dose of LTZ PLGA NPs, there was a slight 
decrease in the gonadosomatic index of LTZ PLGA NPs 
treated groups females, whereas in treated males an  
increase in the dose showed an increase of gonadosomatic 
index. It is evident that ovarian development was  
suppressed significantly (P<0.001) in all the LTZ –loaded 
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Nanoparticles Particle size (nm) Zeta potential Poly dispersive index / normal 
Standard Deviation 
PLGA 132.8±64.8 18.53 mV 0.534 
LTZ- PLGA 216.7±73.5 22.36 mV 0.354 
Table 1. Particle size, zeta-potential and poly dispersive index of PLGA and LTZ-loaded PLGA NPs. 
Mean ± SD of 3 replicates sampled nanoparticles 
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PLGA NPs treated groups, compared to control and T3 
group as indicated by higher GSI values (Table 4 ). The 
testicular development was stimulated considerably in the T2, 
T4, T5, T6 and T7 treated groups. The gonadal development 
(both testicular and ovarian) was normal in control group 
(T1) and PLGA nanoparticle (T2) fed group (Table 4). 
DISCUSSION  
The present work was undertaken to develop an  
efficient and effective delivery system by exploiting 
the emerging application of nanotechnology to  
administrate PLGA nanoencapsulated letrozole for 
altering the sex to be interested in ornamental fish. It is 
equally important that approach should be ecofriendly 
and economically viable, and also user friendly inducing 
agent for male production in fishes, since the nanoparticles 
can be absorbed through cell membrane therefore the 
effect on the target organ is more efficient. 
Nano-encapsulation of letrozole with PLGA 
Nanoparticle: LTZ-loaded PLGA nanoparticles was 
developed size ranging from 78±38.5  nm to 487±73.8 
nm with an average size of 216.7±73.5 nm and  having 
loading capacity of 48.57±6.84 % with  average zeta 
potential of 22.36 mV. This is the first novel report of 
developing nanoparticles for fish sex reversal using 
aromatase inhibitor. However in bio-medical science 
various nanoparticles like Letrozole (LTZ) incorporated 
PLGA nanoparticles have been used to treat cancer (Mondal, 
et al.,2010). 
LTZ-loaded PLGA NPs were prepared by solvent  
displacement technique. This yielded spherical powder  
particles with diameter of LTZ-loaded PLGA nanoparticles  
15–100 nm and poly dispersity index of 0.087±0.019. 
The loading efficiency as well as drug entrapment  
efficiency of LTZ-loaded PLGA NPs was 77.44±0.24 
and 43.03±2.20%, respectively. The zeta potential  
values of LTZ-loaded PLGA NPs were found to be 
negative, −12 to −19.50 mV (Mondal et al., 2010). 
The dexamethezone in PLGA nanoparticles was  
developed for treating disease like rheumatoid, (Park et 
al., 2012).The average size was 50 nm with drug  
loading efficiency was 56.18±5.39 %. 
This is justified that the developed nanoparticle size 
occurred in between the reported nanoparticles size 
and particles are morphologically spherical and  
compact and shown more stable. 
Masculinization using LTZ-loaded PLGA  
nanoparticles: In the present study, LTZ-loaded 
PLGA nanoparticles were administrated at 5, 25, 50 
and 100ppm through diet for 3-day-old fry  (after yolk 
sac absorption) for 10, 15 and 30 days; lead to increase 
masculinization with increased concentration of  
letrozole loaded PLGA nanoparticles. Among  
LTZ-loaded PLGA nanoparticles treated groups, the 
lowest percentage of males (82.63%) was observed in 
5ppm group; while the highest percentage of males 
(100%) was found at 50 and 100 ppm when fed for 30 
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days.Das (2007) observed that the manipulation of the 
sex ratio in Oreochromis mossambicuswas possible by 
oral administration of letrozole (a non-steroidal aroma-
tase inhibitor). Dietary administration of letrozole (100 
and 200 ppm) was produced 92-100% males when fed 
to 5-6 day-old-fry for 30 days. 
Fadrozole was used to masculinization in several spe-
cies like Oncorhynchus tshawytscha (Piferrer et al., 
1994), Epinephelus merra (Nakamura et al., 1998) ,O. 
kisutch (Hong and Donaldson, 1998), Oreochromis 
niloticus (Kwon et al., 2000), Acanthopagrus schlegeli 
(Lee et al., 2001), Cyprinus carpio (Tzchori et al., 
2004), and Siganus guttatus (Komatsu et al., 2006). 
A series of experiments were carried out by Kwon et 
al. (2000) in which genetically female Nile tilapia 
Oreochromis niloticus fry were treated with fadrozole, 
a nonsteroidal aromatase inhibitor, during the period of 
liable phase. Group of tilapia fry medicated with AI 
during the first 30 days following yolk sac reabsorption 
 (7-37 days dph) showed a dose dependent increase in 
the percentage of males. The percentage of males  
remained approximately constant (92.5-96.0%) from 
200-500 mg/kg (Kwon et al., 2000). 
In the present study, a series of experiments were  
carried out to induce masculinization using LTZ-
loaded PLGA nanoparticles during the sex differentia-
tion period. Guppy Poecilia reticulata fry were treated 
with LTZ-loaded PLGA nanoparticles at dosages 5, 
25, 50 and 100 ppm diet for 10, 15 and 30 days. The 
results showed an increase in the proportion of males 
with dosage and duration of treatment and all reported 
works supported the present work. 
Gonopodium index (GPI): In the present research the 
gonopodium index (GPI) of LTZ-loaded PLGA 
nanoparticles treated groups (males) showed a slight 
increase with an increase in the dosage. The treated 
groups (T3, T4, T5, T6 and T7) are significantly differ 
(P< 0.001) from control group (T1) and PLGA 
nanoparticle treated group (T3).  
Gonopodium lengths were unaffected by estradiol ben-
zoate and DDT congeners. However, Bayley et al. 
(2002) showed that juvenile male guppies had smaller 
gonopodium after exposure to vinclozolin, p,p-DDE 
and flutamide. This may be from age-relation. The 
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Treatment 10 days 15 days  30 days 
T1 23.35
a±0.64 23.86a±0.95 23.85a±1.83 
T2 26.64
b±0.46 26.85c±0.47 26.48b±1.56 
T3 23.96
a±0.69 23.64a±1.57 23.69a±1.04 
T4 23.59
a±1.39 24.64b±0.54 26.48b±0.57 
T5 28.35
c±1.07 28.46d±1.54 29.69c±1.98 
T6 29.46
cd±1.03 30.68de±1.05 31.74de±1.54 
T7 30.75
d±1.45 31.46e±1.35 32.64e±1.50 
P value <0.001 <0.001 <0.001 
Table 3. Gonopodial index (GPI) of males of all treated groups. 
Mean ± SD of 3 replicates sampled GPI of males of all treated groups 
10 Days 15 Days 30 Days Treat-
ment   Male Female Male Female Male Female 
T1 2.23
a±1.44 18.47f±0.65 2.20a±1.43 18.42f±1.42 2.75a±0.35 18.54f±1.07 
T2 5.73
e±0.86 14.65e±0.53 5.21c±1.42 14.85e±1.42 5.74d±1.08 14.54e±0.42 
T3 2.75
a±1.07 18.23f±0.64 2.29a±1.54 18.24f±1.34 2.63a±0.85 18.56f±1.65 
T4 3.65
b±0.78 3.64d±0.65 3.67b±0.54 13.36d±0.75 3.64b±1.62 13.56d±0.57 
T5 3.75
c±1.96 12.54c±1.64 3.87b±.1.45 11.67c±1.57 4.66c±0.53 11.57c±1.56 
T6 4.75
d±0.56 11.24b±1.43 4.90c±0.46 10.64b±1.42 5.01d±1.36 10.75b±0.86 
T7 5.95
f±1.86 10.02a±1.54 6.01d±0.53 9.68a±0.35 6.32e±0.15 9.54a±1.54 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Table 4. Gonadosomatic index (GSI) of all treated groups. 
Mean ± SD of 3 replicates sampled GSI of males and females of all treated groups 
399  
gonopodium length was significantly correlated with 
female orientation response to the male (Bayley et al., 
2002). Exposure to LTZ-loaded PLGA nanoparticle 
congeners possibly affects this male sexual character 
since gonopodial development in poeciliids is  
non-steroid dependent. 
Gonadosomatic index (GSI): In the present study the  
gonadosomatic index of LTZ-loaded PLGA nanoparticles 
treated groups (females) showed a slight decrease with 
an increase in the dosage. However, the GSI of males 
increased with an increase in the dosage of LTZ 
-loaded PLGA nanoparticles(Table no.4). Das (2007) 
administered different doses of letrozole alone or in 
combination with 17α-MT and observed that there was 
no major effect of letrozole and 17α-MT on GSI of O. 
mossambicus. The present GIS results of the study 
confirm with those of Piferrer et al. (1994) who  
reported that fadrozole treated genetic females had  
developed into phenotypic males which were indistinguishable 
from regular males in terms of GSI and rate of  
maturity. Ankley et al. (2002) also reported similar 
observations that the GSI of males increased with an 
increase in the dosage of fadrazole which was similar 
with present study results that the GSI of males  
increased with an increase in the dosage of LTZ 
-loaded PLGA nanoparticles. 
Conclusion  
The present study developed a new Letrozole (LTZ) 
-loaded PLGA nanoparticles for effective delivery of 
the masculinization drug.The gonopodium index and 
GSI showed increasing order in male and female  
respectively with dose of LTZ-loaded nanoparticles. 
The use of nanoparticles significantly showed the  
effect on masculinization as compared with naked drug  
delivery. 
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